Christopher Franklin Devall A Ikido Pharma Inc. (AIKI) insider trading activity

Christopher Franklin Devall is COO of AIkido Pharma Inc.. Currently has a direct ownership of 410,702 shares of AIKI, which is worth approximately $1.56 Million. The most recent transaction as insider was on Feb 10, 2025, when has been sold 351,851 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 411K

1267.5% 3M change

1267.5% 12M change

Total Value Held $1.56 Million

Christopher Franklin Devall Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 10 2025	BUY Grant, award, or other acquisition	-	351,851 Added 46.14%	410,702 Common Stock
Feb 10 2025	BUY Open market or private purchase	-	28,818 Added 32.87%	58,851 Common Stock
Dec 26 2023	BUY Open market or private purchase	$17,850 $2.55 p/Share	7,000 Added 18.9%	30,033 Common Stock
Nov 30 2023	BUY Open market or private purchase	$2,280 $2.28 p/Share	1,000 Added 4.16%	23,033 Common Stock
Nov 28 2023	BUY Open market or private purchase	$2,260 $2.26 p/Share	1,000 Added 4.34%	22,033 Common Stock
May 18 2023	BUY Open market or private purchase	$4,410 $2.94 p/Share	1,500 Added 6.66%	21,033 Common Stock
Apr 05 2023	BUY Open market or private purchase	$19,999 $3.51 p/Share	5,698 Added 22.58%	19,533 Common Stock

CFD

Christopher Franklin Devall

COO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIKI shares.

Notify only if

Value

Insider Trading

Get notified when an A Ikido Pharma Inc. insider buys or sells AIKI shares.

Notify only if

Operation

Value

Type

News

Receive news related to AIkido Pharma Inc.

Track Activities on AIKI

Account